Genetics and Epigenetics of Head and Neck Cancer

作者: Richard J. Shaw , Jagtar Dhanda

DOI: 10.1007/978-1-4419-9464-6_5

关键词:

摘要: Our ability to explore the cancer genome is dependent upon, and limited by, availability of representative tumour models, high-quality tissue resource capacity available technologies. Fortunately, there has been great progress in these areas recent years with next-generation sequencing techniques enabling entire sequencing, using a fraction resources previously required. Carcinogenesis multistep multifactorial process that involves multiple genes critical events occurring at DNA level highly stable macromolecule therefore an excellent for biomarker discovery. However, translational perspectives genomics remain which partly related intratumour heterogeneity, subclones cells can be present within same tumour. New advances therapy will rely upon greater understanding molecular basis this new therapies have target specific characteristics individual’s tumour, central modern concept personalised medicine. There however emerging classification HNSCC, prognostic significance, based presence human papillomavirus number genomic alterations present.

参考文章(134)
C. René Leemans, Boudewijn J. M. Braakhuis, Ruud H. Brakenhoff, The molecular biology of head and neck cancer Nature Reviews Cancer. ,vol. 11, pp. 9- 22 ,(2011) , 10.1038/NRC2982
Arnold J Levine, p53, the Cellular Gatekeeper for Growth and Division Cell. ,vol. 88, pp. 323- 331 ,(1997) , 10.1016/S0092-8674(00)81871-1
Shaun D Fouse, Raman P Nagarajan, Joseph F Costello, Genome-scale DNA methylation analysis. Epigenomics. ,vol. 2, pp. 105- 117 ,(2010) , 10.2217/EPI.09.35
J. G. Herman, J. R. Graff, S. Myohanen, B. D. Nelkin, S. B. Baylin, Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands Proceedings of the National Academy of Sciences of the United States of America. ,vol. 93, pp. 9821- 9826 ,(1996) , 10.1073/PNAS.93.18.9821
Kouji Banno, Megumi Yanokura, Makiko Kawaguchi, Yoshiko Kuwabara, Jyunko Akiyoshi, Yusuke Kobayashi, Takashi Iwata, Akira Hirasawa, Takuma Fujii, Nobuyuki Susumu, Kastumi Tsukazaki, Daisuke Aoki, Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes. International Journal of Oncology. ,vol. 31, pp. 713- 720 ,(2007) , 10.3892/IJO.31.4.713
David Sidransky, Molecular genetics of head and neck cancer Current Opinion in Oncology. ,vol. 7, pp. 229- 233 ,(1995) , 10.1097/00001622-199505000-00007
Bert Vogelstein, Kenneth W. Kinzler, The multistep nature of cancer. Trends in Genetics. ,vol. 9, pp. 138- 141 ,(1993) , 10.1016/0168-9525(93)90209-Z
M.F. Santibáñez-Koref, J.M. Birch, A.L. Hartley, D. Crowther, M. Harris, P.H. Morris Jones, A.M. Kelsey, A.W. Craft, T. Eden, p53 germline mutations in Li-Fraumeni syndrome The Lancet. ,vol. 338, pp. 1490- 1491 ,(1991) , 10.1016/0140-6736(91)92303-J
Igor V Garkavtsev, Nikolai Kley, Irina A Grigorian, Andrei V Gudkov, The Bloom syndrome protein interacts and cooperates with p53 in regulation of transcription and cell growth control Oncogene. ,vol. 20, pp. 8276- 8280 ,(2001) , 10.1038/SJ.ONC.1205120